2025 first_quarter Filing

Monitored the implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to drug pricing.
H.R. 946, ORPHAN Cures Act. Issues related to access to home infusion. Issues related to pharmacy benefit management reforms.

H.R. 1990, the American Innovation and R&D Competitiveness Act, as it relates to the R&D tax credit. Monitored H.R. 591, Defending American Jobs & Investment Act and H.R. 2423, Unfair Tax Prevention Act, as they relate to taxation of foreign-based multinationals. Issues related to the 2025 extension of the Tax Cut and Jobs Act provisions impacting corporations and the Orphan Drug Tax Credit.

Issues related to medication step therapy.
S.864, HELP Copays Act, as it relates to out-of-pocket costs for prescription drugs. Issues related to pharmacy benefit management reforms.

Issues related to tariffs.